Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.1.7SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BQ.1.1.7SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BQ.1.1.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.2.6ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
XBB.2.6ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
XBB.2.6SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XBB.2.6SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
XBB.2.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.2.1ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
FL.2.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
FL.2.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
FL.2.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
FL.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.2.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GD.2ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
GD.2ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
GD.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
GD.2SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
GD.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GD.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GD.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GD.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBZORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
XBZORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
XBZSWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XBZSWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
XBZEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XBZEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBZNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBZNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BR.2.1ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
BR.2.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BR.2.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BR.2.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BR.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BR.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BR.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BR.2.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.79ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
BQ.1.1.79ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BQ.1.1.79SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BQ.1.1.79SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used